Calcium carbonate supplementation for the prevention of preeclampsia in high-risk pregnant women: a randomized clinical trial protocol

Cinara Rejane Viana Oliveira,Camille Lima Resende,Sabrina Joany Felizardo Neves,Alessandra Rezende Mesquita,Alfredo Dias de Oliveira-Filho
DOI: https://doi.org/10.1186/s13063-024-08489-9
IF: 2.728
2024-10-05
Trials
Abstract:Preeclampsia (PE) is a significant cause of maternal mortality worldwide, affecting 2% to 8% of pregnancies. The World Health Organization recommends the use of low-dose acetylsalicylic acid (100 mg of aspirin) and 1.5 to 2 g of calcium carbonate during pregnancy to prevent PE. However, robust evidence supporting the efficacy of calcium supplementation is still needed. This study aims to assess the efficacy of calcium carbonate in preventing preeclampsia in high-risk pregnant women.
medicine, research & experimental
What problem does this paper attempt to address?